PTCE In-Person, Hybrid, & Virtual CE-Accredited Events
Browse Upcoming Live Webinars & Events
Listed by date, soonest first. See them on the calendar.
All Upcoming Events
20 results|Sorted by: Event Date
Breakthroughs Continue in the Treatment of Systemic Lupus Erythematosus and Lupus Nephritis: Updating Managed Care Approaches
Virtual Symposium
Managed Care Pharmacist
November 11, 2026
Optimizing Access and Outcomes in Chronic Spontaneous Urticaria: Evaluating the Therapeutic Landscape Through a Managed Care Lens
Webinar
Managed Care Pharmacist
Next session: November 11, 2026Then November 16 and November 30, 2026
Reframing Cardiorenal-Metabolic Care: Advancing SGLT2 Inhibitors From Evidence to Implementation
Virtual Symposium
Managed Care Pharmacist
November 12, 2026
Beyond Progression: Evidence Pathways for Oral SERDs in HR+/HER2– Metastatic Breast Cancer
Webinar
Oncology Pharmacist
Next session: November 13, 2026Then November 16, 2026
Closing the Gap in Lipid Management: Guideline-Concordant Care and Nonstatin Advances Across the Health-System Continuum
Webinar
Managed Care Pharmacist
November 17, 2026
Talking Shots: A Pharmacist’s Guide to Evidence-Based Vaccine Conversations
Webinar
Community Pharmacist
November 18, 2026
The Evolving IgA Nephropathy Landscape: Translating New Evidence and Updated Guidelines Into Managed Care Access Strategies
Webinar
Managed Care Pharmacist
Next session: November 19, 2026Then December 1 and December 16, 2026
Advancing Evidence-Based Value in Transthyretin Amyloidosis Cardiomyopathy Care: Managed Care Strategies for Early Identification, Access, and Treatment
Webinar
Managed Care Pharmacist
November 23, 2026
Two Targets, One Mission: A Pharmacist’s Guide to Bispecific Antibodies in Lymphoma
Webinar
Oncology Pharmacist
December 1, 2026
SERD Strategy Lab: A Blueprint for Pharmacist-Led Implementation of Oral SERDs in HR+/HER2– Metastatic Breast Cancer
Webinar
Oncology Pharmacist
December 2, 2026
Bispecific Antibodies in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma: Clinical Evidence and Evolving Treatment Strategies
Webinar
Oncology Pharmacist
December 3, 2026
Continuing the Conversation: Optimizing Fibrosing ILD Outcomes: A Pharmacist-Led Approach to Evidence-Based Care
Virtual Event
Health-System PharmacistConsultant Pharmacist+1
December 3, 2026
ASHP Midyear 2026
In-Person + Virtual Event
Ambulatory Care PharmacistSpecialty Pharmacist+1
December 8–9, 2026
PROC in Practice: Navigating Biomarkers, Pipeline, and Patient Safety in Platinum-Resistant Ovarian Cancer
Webinar
Oncology PharmacistSpecialty Pharmacist
December 10, 2026
Precision Sequencing in Advanced GEA: Advanced Pharmacist Strategies for Targeting HER2 and CLDN18.2
Webinar
Oncology Pharmacist
December 14, 2026
Bispecific Antibodies in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma: Proactive Toxicity Recognition and Management in Clinical Practice
Webinar
Oncology Pharmacist
December 15, 2026
Weighing In: Optimizing GLP-1 RA and Dual GIP/GLP-1 RA Therapy Through Comprehensive Patient Care and Nutrition
Panel Discussion
Community Pharmacist
December 15, 2026
APOL1-Mediated Kidney Disease: Preparing Pharmacists for a New Era of Targeted Therapy
Webinar
Specialty Pharmacist
December 18, 2026
